共 50 条
- [21] Cyclodextrins - Enabling excipients: Their present and future use in pharmaceuticals. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U239 - U239
- [22] Quality of sleep for osteoarthritis patients using pharmaceuticals. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1407 - 1407
- [23] Biolocalization and in vivo coordination chemistry of vanadium pharmaceuticals. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U769 - U769
- [24] Multicomponent Crystals in the Development of New Solid Forms of Pharmaceuticals. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S102 - S102
- [25] Pricing and reimbursement of pharmaceuticals. A new culture for the community pharmacist PHARMACY WORLD & SCIENCE, 1998, 20 (03): : 107 - 112
- [26] Second-generation PEG-protein pharmaceuticals. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U293 - U293
- [27] Practical aspects of setting occupational exposure limits for pharmaceuticals. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U275 - U275
- [28] The significance of complex formations and solubility changes for the action of pharmaceuticals. NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE, 1936, 181 : 503 - 511
- [30] Pollution of the aquatic environment with pharmaceuticals. Strategic approach to the problem PRZEMYSL CHEMICZNY, 2021, 100 (09): : 850 - 853